about
Ebola and its control in Liberia, 2014-2015Initiation of a ring approach to infection prevention and control at non-Ebola health care facilities - Liberia, January-February 2015Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural dataEbola virus disease in West Africa--the first 9 months of the epidemic and forward projectionsReduced evolutionary rate in reemerged Ebola virus transmission chainsNanopore Sequencing as a Rapidly Deployable Ebola Outbreak ToolEbola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015Mortality, Morbidity and Health-Seeking Behaviour during the Ebola Epidemic 2014-2015 in Monrovia Results from a Mobile Phone SurveyReducing under-reporting of stigmatized health events using the List Experiment: results from a randomized, population-based study of abortion in LiberiaEstimation of maternal and neonatal mortality at the subnational level in LiberiaAssessment of ebola virus disease, health care infrastructure, and preparedness - four counties,Southeastern Liberia, august 2014.Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funeralsRebuilding human resources for health: a case study from Liberia.Evolution of ebola virus disease from exotic infection to global health priority, Liberia, mid-2014Repetition of a sisterhood survey at district level in Malawi: the challenge to achieve MDG 5.A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in MalawiInterpretation of Negative Molecular Test Results in Patients With Suspected or Confirmed Ebola Virus Disease: Report of Two Cases.The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak.Psychological Distress among Ebola Survivors Discharged from an Ebola Treatment Unit in Monrovia, Liberia - A Qualitative Study.Operational research in low-income countries: what, why, and how?Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola.Does this patient have Ebola virus disease?Ebola virus disease cases among health care workers not working in Ebola treatment units--Liberia, June-August, 2014.Impact of interventions and the incidence of ebola virus disease in Liberia-implications for future epidemics.Implementation of a National Semen Testing and Counseling Program for Male Ebola Survivors - Liberia, 2015-2016.Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives.Ebola epidemic--Liberia, March-October 2014.Beyond Ebola treatment units: severe infection temporary treatment units as an essential element of Ebola case management during an outbreak.Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care.Risk factors for mortality in AIDS-associated Kaposi sarcoma in a primary care antiretroviral treatment program in Malawi.Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengthening.Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models.Outbreaks in a Rapidly Changing Central Africa — Lessons from EbolaOutbreaks in a Rapidly Changing Central Africa - Lessons from EbolaEffect of Mass Artesunate-Amodiaquine Distribution on Mortality of Patients With Ebola Virus Disease During West African Outbreak
P50
Q23922910-6E00665B-DD25-4652-8BCE-39A50D5BC597Q24849516-899ABB68-5F42-440F-8ABE-A1558A24843AQ27478553-47533DAE-8DF2-425A-916D-A2BCB48B60DDQ28248431-E76AF8E3-FB2B-4F30-96F4-C79EEC263FA3Q28383109-FFC4CC5D-D707-4ACB-8D0A-8A19F95BA2F4Q28385526-82379B97-8F43-4D0F-97AD-68BC3D4AD392Q28390874-27E77FDD-70A1-434B-A3D1-D99FD4509154Q28553678-9E66CC89-045B-4BCE-BC05-A06BF89DCAFAQ28587185-41BAF401-E472-4A87-9960-056DE6699D84Q28654678-83D83038-3E05-45F0-A260-8D9AAE15D14AQ30207660-31151150-8183-4DE4-BB92-11BC030E8902Q33573384-38A09BE8-6DB3-40C1-912A-06C424BD4C93Q35052896-681C6FAB-1E1F-475B-80E8-34BE938830B1Q35229710-92129159-8B53-4A47-8366-D411749C8620Q35320233-2623B4C4-4945-4225-B684-11CED9BB7930Q35917568-A0C0117C-8E4A-4E20-BCEE-EC68A2A53B5EQ36209320-26E0CF91-3CFE-4272-BB52-AF0290ABF774Q36525287-AEE96065-751F-4F45-AFD8-1E82FFA57C6FQ37060924-F3F7C4FB-99D1-41FE-B4E9-C15B3637CFFBQ37619854-C8BE1F57-4870-4523-8A4D-8C42EB27524BQ37722368-DE81A491-1FE8-4685-801D-429B6AB7A69EQ38245691-48DF279D-E526-493D-931F-15D2E11F9375Q38393896-F4D099E0-3377-4792-B832-A6E44362A546Q38756706-B2AA7CCE-F8A5-4BED-A6CD-01CF1B0EC4A8Q39386052-D9668C7F-3C99-4907-BA20-F0B00809AD29Q40092348-69A3A348-12F9-4817-86BA-4C77EBB84242Q40094840-AB962E8A-797C-431D-A618-A916F79BBAAAQ40123521-B20CD8C2-E905-4CFF-A397-0AC18FE49B5AQ40182235-25F4007C-8050-49A5-9397-46D9DE4FAD86Q42323438-694EE58B-7F91-48EC-90CB-2BB0201E25F8Q43876514-09708AB8-E0DC-4DD8-A1D2-A78CE4C14A3DQ44434854-CCD20D8D-4C05-4D34-B488-CF7A4A214EFAQ46346006-5F726E00-2520-4A14-A38C-0BD3203815F5Q46355991-7C490543-D985-47DC-AC9B-6A8011684D8DQ47557830-5137D213-7B69-4B47-BA22-C5C0229C9CDBQ54217122-AB8CAAC1-0220-48F6-8B24-58F844CA34E4Q58984940-32F79D55-CD58-4E2E-AEDC-94DE477D4554Q59354092-C31A1E7D-FF84-4AB9-9B10-F9BDC9CEA553Q91693293-F0ED850D-FABF-44C2-9267-98A922D9E14A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Moses Massaquoi
@ast
Moses Massaquoi
@en
Moses Massaquoi
@es
Moses Massaquoi
@nl
type
label
Moses Massaquoi
@ast
Moses Massaquoi
@en
Moses Massaquoi
@es
Moses Massaquoi
@nl
prefLabel
Moses Massaquoi
@ast
Moses Massaquoi
@en
Moses Massaquoi
@es
Moses Massaquoi
@nl
P106
P31
P496
0000-0001-6732-5422